Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort

Authors :: Malin, Petersson
Amalia, Feresiadou
Daniel, Jons
Andreea, Ilinca
Fredrik, Lundin
Rune, Johansson
Anna, Budzianowska
Anna-Karin, Roos
Viktor, Kågström
Martin, Gunnarsson
Peter, Sundström
Fredrik, Piehl
Susanna, Brauner
Source :: Neurology, article-version (Version of Record) 3
Publication Year :: 2021
Publisher :: Lippincott Williams & Wilkins, 2021.
Abstract: Background and Objectives To describe myasthenia gravis activities of daily living (MG-ADL) in relation to clinical characteristics in a large Swedish nationwide cohort. Methods In a cross-sectional prevalence cohort study, the Genes and Environment in Myasthenia Gravis study, performed from November 2018 through August 2019, patients with myasthenia gravis (MG) were invited to submit an extensive 106-item life environment questionnaire, including the MG-ADL score. Patients were classified into early-onset MG (EOMG